Part of Thermo Fisher Scientific
26 August 2003
Oxoid Acquires Prepared Media Manufacturing Operations from Medvet Science Pty Limited
Oxoid Ltd has reached agreement to acquire the Prepared Media and Diagnostics assets of Medvet Science Pty Ltd, Australia. From early September 2003, Oxoid will take direct control of the Medvet manufacturing operations in Adelaide - a purpose-built facility created less than three years ago. A total of 26 staff are expected to transfer and become Oxoid employees.
"This acquisition brings together two like-minded companies", says Mike Smith, President, Oxoid. "Medvet has been involved in the development and implementation of quality standards for culture media in Australia. Oxoid has an enviable reputation worldwide for its high quality products, distribution network and commitment to R&D. Our main objective is excellence in customer service and this latest acquisition fits with this strategy."
Wayne Chitty, Chief Executive Officer of Oxoid Australia said, "We have worked closely with Medvet for many years. This acquisition demonstrates Oxoid’s commitment to the Australasian and Asia Pacific markets and allows us to extend the range of products and services that we provide within these regions."
Oxoid will also acquire the Microbact™ biochemical identification systems and Serobact™ rapid latex agglutination tests, which will be marketed worldwide under the Oxoid brand.